Literature DB >> 8125825

Irradiation of nonlymphoproliferative neoplasms of the nasal cavity and paranasal sinuses in 16 cats.

A P Théon1, A E Peaston, B R Madewell, D L Dungworth.   

Abstract

Sixteen cats with malignant tumors (10 carcinomas, 6 sarcomas) of the nasal cavity and paranasal sinuses were treated with curative intent by radiotherapy. Clinical stating was based on radiographic findings, using the tumor, node, metastasis classification system of the World Health Organization. Irradiation was done with a telecobalt-60 unit (13 cats) and an orthovoltage unit (3 cats). Fourteen cats were treated with irradiation alone, and 2 cats had incomplete surgical resections prior to radiotherapy. Treatment dose was 48 Gy (minimum tumor dose), administered by use of 4 Gy per fraction on a Monday/Wednesday/Friday basis over 4 weeks. Survival times after treatment ranged from 1 to 36 months. The 1- and 2-year overall survival rates were 44.3 and 16.6%, respectively. Histologic type and clinical stage did not have prognostic value. Most acute radiation reactions were mild and self-limiting. Chronic ocular complications were seen in 3 cats. These treatment responses compared favorably with those previously described in dogs and cats with intranasal neoplasms treated with teletherapy and provided a perspective for comparison of new treatment methods.

Entities:  

Mesh:

Year:  1994        PMID: 8125825

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  2 in total

1.  Surgical and localized radiation therapy for an intranasal adenocarcinoma in a rabbit.

Authors:  Makoto Nakata; Yasutsugu Miwa; Masaya Tsuboi; Kazuyuki Uchida
Journal:  J Vet Med Sci       Date:  2014-09-03       Impact factor: 1.267

2.  Retrospective evaluation of intranasal carcinomas in cats treated with external-beam radiotherapy: 42 cases.

Authors:  Hiroto Yoshikawa; Tracy L Gieger; Corey F Saba; Kirsha Fredrickson; Lyndsay Kubicek; Siobhan Haney; David Ruslander; Krista L Kelsey; Margaret C McEntee; Michael W Nolan
Journal:  J Vet Intern Med       Date:  2021-03-03       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.